Novo Nordisk and Lundbeck reprimanded for breaching UK marketing laws
![Photo: Tidsvilde Stine/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14729099/kew0os/ALTERNATES/schema-16_9/20160929-062243-pf-4928x2770ma%2520(1).jpg)
Novo Nordisk and Lundbeck have found themselves in the crosshairs of UK authority Prescription Medicines Code of Practice Authority (PMCPA).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk enters USD 6.3m legal settlement in US
For subscribers
EU Commission accuses Teva of breaking antitrust laws
For subscribers
Zealand Pharma sued over misusing trade secrets
For subscribers